Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12637)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2020 (publication date) through Jan 9, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Zeng J, Yang RX, Sun C, Pan Q, Zhang RN, Chen GY, Hu Y, Fan JG. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease. World J Gastroenterol 2020; 26(15): 1792-1804 [PMID: 32351294 DOI: 10.3748/wjg.v26.i15.1792] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Zeng J, Yang RX, Sun C, Pan Q, Zhang RN, Chen GY, Hu Y, Fan JG. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease. World J Gastroenterol 2020; 26(15): 1792-1804 [PMID: 32351294 DOI: 10.3748/wjg.v26.i15.1792] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i15/1792.htm |
| Number | Citing Articles |
| 1 |
Shang-Yu Chai, Ru-Ya Zhang, Gail Fernandes, Yi-Man Zheng, Lai Wei. Epidemiology of metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis and associated cardiometabolic factors in adults in China (2013-2023): A systematic review and meta-analysis. World Journal of Gastroenterology 2025; 31(46): 113608 doi: 10.3748/wjg.v31.i46.113608
Abstract(26) |
Core Tip(24) |
Full Article(HTML)(213)
|
Full Article with Cover (PDF)-3949K(23)
|
Audio-1440K(5)
|
Peer-Review Report-246K(11)
|
Answering Reviewers-196K(13)
|
Supplementary Material-1540K(14)
|
Full Article (PDF)-3605K(40)
|
Full Article (XML)-179K(9)
|
Times Cited (0)
|
Total Visits (740)
|
Open
|
| 2 |
Anand K. Pyati, Sakthivadivel Varatharajan, Abhishek Arora, Vaman Kulkarni, Aparna Varma Bhongir, Sangeetha Sampath, Gomathi Ramaswamy, Madhu Latha Karra, Priyanka Das, Pawan Pagaku. Study of association and diagnostic utility of novel anthropometric and lipid indices for nonalcoholic fatty liver disease: A hospital-based study. Journal of Family Medicine and Primary Care 2025; 14(6): 2365 doi: 10.4103/jfmpc.jfmpc_1609_24
|
| 3 |
Naoto Hashimoto, Kyu-Ho Han, Manabu Wakagi, Yuko Ishikawa-Takano, Katsunari Ippoushi, Michihiro Fukushima. Bile acids induced hepatic lipid accumulation in mice by inhibiting mRNA expression of patatin-like phospholipase domain containing 3 and microsomal triglyceride transfer protein. Nutrition Research 2021; 92: 12 doi: 10.1016/j.nutres.2021.05.006
|
| 4 |
Gerard Stupecki, Emilia Kowalczyk, Agnieszka Ciba-Stemplewska, Magdalena Dolecka-Ślusarczyk, Iwona Gorczyca-Głowacka. Metabolic dysfunction-associated steatotic liver disease: Prevalence and progression in lean patients. Polish Annals of Medicine 2025; : 1 doi: 10.29089/paom/203734
|
| 5 |
Kemin Li, Ji Li, Xiaoyun Cheng, Jing Wang, Jingnan Li. Association between the atherogenic index of plasma and new-onset non-alcoholic fatty liver disease in non-obese participants. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.969783
|
| 6 |
Xiaojuan Wu, Ying Wang, Yumei Jia, Jia Liu, Guang Wang, Ferdinando Carlo Sasso. Risk Factors for Nonalcoholic Fatty Liver Disease with Different Insulin Resistance in a Nonobese Chinese Population. Journal of Diabetes Research 2022; 2022: 1 doi: 10.1155/2022/9060405
|
| 7 |
Xian Wen, Leibo Wang, Kaiyi Mao. The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality, a nationwide cohort study:comment. Internal and Emergency Medicine 2025; 20(7): 2271 doi: 10.1007/s11739-025-03969-5
|
| 8 |
Rui Xue, Rui Xu Yang, Jian Gao Fan. Epidemiological trends and clinical characteristic of NAFLD/MAFLD in Asia. Journal of Digestive Diseases 2022; 23(7): 354 doi: 10.1111/1751-2980.13117
|
| 9 |
Qian Gao, Lei Feng, Weiling Zhou, Xiaoli Li, Lanzi Yin, Yuan Wang. Non-Traditional Blood Lipid Indices for Metabolism Dysfunction-Associated Fatty Liver Disease Prediction in Non-Obese Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity 2023; : 2345 doi: 10.2147/DMSO.S418020
|
| 10 |
Haohong Zhan, Xiaoli Nong, Senzhi Zhu, Ting Luo, Tian Li, Mingjing Cao, Qi Li, Zhuosen He, Junyan Hu, Xi Liu. Clinical value of γ-glutamyl transpeptidase to platelet ratio and triglyceride measurement in the diagnosis of nonalcoholic fatty liver disease: A cross-sectional study. Heliyon 2024; 10(16): e36193 doi: 10.1016/j.heliyon.2024.e36193
|
| 11 |
Kongting Xing, Chaoying Ge, Lingli Xu, Linjian Liu. Association of waist-to-height ratio with nonalcoholic fatty liver disease and liver fibrosis detected by vibration-controlled transient elastography: NHANES 2017-2020. Medicine 2026; 105(1): e46675 doi: 10.1097/MD.0000000000046675
|
| 12 |
Song Xiao, Ziqi Chen, Tingyu Mai, Jiansheng Cai, Yulu Chen, Xu Tang, Ruoyu Gou, Tingyu Luo, Kailian He, Tingjun Li, Jian Qin, Zhiyong Zhang, You Li. Analysis of the association between dietary patterns and nonalcoholic fatty liver disease in a county in Guangxi. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02864-7
|
| 13 |
Xueying Wang, Song Leng. Serum uric acid may be a mediator of risk factors in metabolic dysfunction associated steatotic liver disease. Scandinavian Journal of Gastroenterology 2025; 60(6): 581 doi: 10.1080/00365521.2025.2490994
|
| 14 |
Melchor Alpízar Salazar, Samantha Estefanía Olguín Reyes, Andrea Medina Estévez, Julieta Alejandra Saturno Lobos, Jesús Manuel De Aldecoa Castillo, Juan Carlos Carrera Aguas, Samary Alaniz Monreal, José Antonio Navarro Rodríguez, Dulce María Fernanda Alpízar Sánchez. Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma. Medicina 2025; 61(1): 88 doi: 10.3390/medicina61010088
|
| 15 |
Zhen Song, Hai-Qi Gu, Cheng Xu. Association of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease and hepatic steatosis in United States adults: insights from NHANES 2017–2020. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1540903
|
| 16 |
Yilin Zhang, Minhua Li, Shanshan Du, Yifeng Chen, Qingyu Li, Zitong Zhang, Rong Xu, Qing Zu, Zihu Lv, Weimin Ye, Wei Zheng, Jianjun Xiang. Machine learning-driven analysis of occupational heat exposure and metabolic associated fatty liver disease in petrochemical workers. Ecotoxicology and Environmental Safety 2026; 309: 119512 doi: 10.1016/j.ecoenv.2025.119512
|
| 17 |
Ines Bilic-Curcic, Maja Cigrovski Berkovic, Lucija Virovic-Jukic, Anna Mrzljak. Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals . World Journal of Hepatology 2021; 13(1): 80-93 doi: 10.4254/wjh.v13.i1.80
|
| 18 |
Nachum Lebovics, Gabriel Heering, William H. Frishman, Edward Lebovics. Lean MASLD and Cardiovascular Disease: A Review. Cardiology in Review 2025; doi: 10.1097/CRD.0000000000000893
|
| 19 |
Ran Lu, Ye Liu, Tianpei Hong. Epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China: A narrative review. Diabetes, Obesity and Metabolism 2023; 25(S1): 13 doi: 10.1111/dom.15014
|
| 20 |
Soyoung Hur, Soyeon An, Eujin Kim, Cho-Hyun Hwang, Eungyeong Jang, Youngchul Kim, Jang-Hoon Lee. Case Report of a Patient Diagnosed with Fatty Liver Accompanied by Hypertriglyceridemia. The Journal of Internal Korean Medicine 2021; 42(2): 207 doi: 10.22246/jikm.2021.42.2.207
|
| 21 |
Abdulrahman Ismaiel, Blal El Hosiny, Mohamed Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Cristina Sorina Catana, Dan L. Dumitrascu. Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102160 doi: 10.1016/j.clinre.2023.102160
|
| 22 |
Yi Du, Kendra L. Ratnapradipa, Dejun Su, Jianghu Dong, Fedja A. Rochling, Paraskevi A. Farazi. Effects of Interventions for Improving Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Chinese Young Adults for Prevention of Liver Cancer—A Randomized Controlled Trial. Journal of Cancer Education 2024; 39(3): 253 doi: 10.1007/s13187-024-02404-1
|
| 23 |
Satoko Takahashi, Marenao Tanaka, Yukimura Higashiura, Kazuma Mori, Nagisa Hanawa, Hirofumi Ohnishi, Masato Furuhashi. Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population. Endocrine Journal 2022; 69(4): 463 doi: 10.1507/endocrj.EJ21-0563
|
| 24 |
Ruixu Yang, Qian Jin, Jiangao Fan. Metabolic dysfunction-associated fatty liver disease: from basic research to clinical application. Chinese Medical Journal 2022; 135(10): 1138 doi: 10.1097/CM9.0000000000002136
|
| 25 |
Ansel Tang, Cheng Han Ng, Poh Hui Phang, Kai En Chan, Yip Han Chin, Clarissa Elysia Fu, Rebecca Wenling Zeng, Jieling Xiao, Darren Jun Hao Tan, Jingxuan Quek, Wen Hui Lim, Lung Yi Mak, Jiong-wei Wang, Nicholas W.S. Chew, Nicholas Syn, Daniel Q. Huang, Mohammad Shadab Siddiqui, Arun Sanyal, Mark Muthiah, Mazen Noureddin. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2023; 21(7): 1750 doi: 10.1016/j.cgh.2022.06.029
|
| 26 |
Ziqin Lai, Zhu Li, Mengnan Huang, Yang Wang, Lin Li, Fanfan Liu, Tong Yang, Yijia Liu, Qiang Xu, Shan Gao, Chunquan Yu. Associations Between GGT/ALT Ratio and Carotid Plaque in Inpatients With Coronary Artery Disease: A RCSCD-TCM Study. Angiology 2025; 76(1): 40 doi: 10.1177/00033197231197441
|
| 27 |
Yanhui Lin, Min Fu, Ren Lin, Min Hong, Zhian Zheng, Jiangang Wang, Ting Peng, Tao Wang. Trends in the prevalence of steatotic liver disease among Chinese adults, 2015–2023: A nationwide cross-sectional study. Hepatology Communications 2025; 9(9) doi: 10.1097/HC9.0000000000000785
|
| 28 |
Qinqiu Wang, Xiaoying Shi, Jinghua Wang, Juanwen Zhang, Chengfu Xu. Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study. Nutrition Journal 2021; 20(1) doi: 10.1186/s12937-021-00690-9
|
| 29 |
Guotai Sheng, Qiyang Xie, Rongsheng Wang, Chong Hu, Mingchun Zhong, Yang Zou. Waist-to-height ratio and non-alcoholic fatty liver disease in adults. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01824-3
|
| 30 |
Haozhe Cui, Yongliang Chen, Zhiming Zhao. The dynamic patterns of metabolic-associated fatty liver disease and its severity and risk of cardiovascular disease. Hepatology International 2025; 19(1): 131 doi: 10.1007/s12072-024-10745-8
|
| 31 |
Lampros Chrysavgis, Eleftheria Ztriva, Adonis Protopapas, Konstantinos Tziomalos, Evangelos Cholongitas. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management. World Journal of Gastroenterology 2020; 26(42): 6514-6528 doi: 10.3748/wjg.v26.i42.6514
|
| 32 |
Basile Njei, Prince Ameyaw, Yazan Al-Ajlouni, Lea-Pearl Njei, Sarpong Boateng. Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review. Cureus 2024; doi: 10.7759/cureus.71451
|
| 33 |
Ying-Xin Xian, Jian-Ping Weng, Fen Xu. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chinese Medical Journal 2021; 134(1): 8 doi: 10.1097/CM9.0000000000001263
|
| 34 |
Evangelia Makri, Antonis Goulas, Stergios A. Polyzos. Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. Archives of Medical Research 2021; 52(1): 25 doi: 10.1016/j.arcmed.2020.11.010
|
| 35 |
Jie Li, Na Wu, Yukun Yang, Xiangyu Zhai, Fan Yuan, Fengwei Zhang, Ning Yu, Dong Li, Ruirui Wang, Jianying Wang, Lei Zhang, Yi Shi, Guang He, Baocheng Liu. Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study. BMC Endocrine Disorders 2023; 23(1) doi: 10.1186/s12902-022-01234-w
|
| 36 |
Yuping Ding, Quanjun Deng, Mei Yang, Haiyan Niu, Zuoyu Wang, Shihai Xia. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment. Diabetes, Metabolic Syndrome and Obesity 2023; : 3303 doi: 10.2147/DMSO.S431251
|
| 37 |
Zahra Yari, Danial Fotros, Azita Hekmatdoost. Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-41893-w
|
| 38 |
Saleh Alqahtani, Rajaa Al-Raddadi, Ghada Ajabnoor, Zeyad Alraddadi, Jawaher Alahmadi, Adel Alhabash, Rehad Hakim, Loojen Alseraihi, Suhad Bahijri. Usefulness of Neck Circumference, Waist-to-Height Ratio and Waist-to-Hip Ratio in Predicting Non-Alcoholic Fatty Liver Disease in Saudi Population Without Type 2 Diabetes. Nutrition and Metabolic Insights 2024; 17 doi: 10.1177/11786388241259942
|
| 39 |
Mariana Boulos, Rabia S. Mousa, Nizar Jeries, Elias Simaan, Klode Alam, Bulus Bulus, Nimer Assy. Hidden in the Fat: Unpacking the Metabolic Tango Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Syndrome. International Journal of Molecular Sciences 2025; 26(7): 3448 doi: 10.3390/ijms26073448
|
| 40 |
Xin-Juan Huang, Man Yin, Bing-Qian Zhou, Xin-Yun Tan, Yuan-Qin Xia, Chun-Xiang Qin. Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors. World Journal of Hepatology 2023; 15(8): 985-1000 doi: 10.4254/wjh.v15.i8.985
Abstract(1050) |
Core Tip(761) |
Full Article(HTML)(2819)
|
Full Article with Cover (PDF)-3083K(193)
|
Full Article (Word)-529K(33)
|
Audio-1427K(5)
|
Peer-Review Report-233K(106)
|
Answering Reviewers-583K(135)
|
Full Article (PDF)-1305K(248)
|
Full Article (XML)-166K(117)
|
Times Cited (11)
|
Total Visits (12203)
|
Open
|
| 41 |
Amrita Kandel, Poonam Pant, Sushila Todi, Sudhamshu KC, Sudip Pandey. Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease. SAGE Open Medicine 2024; 12 doi: 10.1177/20503121241227090
|
| 42 |
Yi-wen Shi, Jian-Gao Fan. Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis. Clinical and Molecular Hepatology 2023; 29(Suppl): S228 doi: 10.3350/cmh.2022.0401
|
| 43 |
Jingyue Zhang, Yingming Zhang, Ze Ren, Dongmei Yan, Guiying Li. The role of TRIM family in metabolic associated fatty liver disease. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1210330
|
| 44 |
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia, Mohammadreza Farzanehfar. A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals. Journal of Gastroenterology and Hepatology 2021; 36(6): 1497 doi: 10.1111/jgh.15353
|
| 45 |
Ann Margaret C. Navarroza, Stephen N. Wong. Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease. Indian Journal of Gastroenterology 2021; 40(4): 380 doi: 10.1007/s12664-021-01184-6
|
| 46 |
Xiuli Wang, Jie Liu, Ke Yu, Zhenhua Huang, Hanxiong Liu, Xiang Li. Association between TyG-related parameters and NAFLD risk in Japanese non-obese population. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-88478-3
|
| 47 |
Chunxia Zhai, Xiaorong Ding, Anqi Huang, Yang Ge, Fan Yang, Yi Ding. Causal associations of single anthropometric measures and body shape with nonalcoholic fatty liver disease: A Mendelian randomization study. Medicine 2025; 104(27): e43108 doi: 10.1097/MD.0000000000043108
|
| 48 |
Haoxuan Zou, Xiaopu Ma, Wen Pan, Yan Xie. The association of the metabolic score for insulin resistance and metabolic dysfunction-related steatosis liver disease: a population-based observational study. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02936-2
|
| 49 |
Mohammed Eslam, Hashem B. El-Serag, Sven Francque, Shiv K. Sarin, Lai Wei, Elisabetta Bugianesi, Jacob George. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nature Reviews Gastroenterology & Hepatology 2022; 19(10): 638 doi: 10.1038/s41575-022-00635-5
|
| 50 |
Haofei Hu, Yong Han, Yufei Liu, Mijie Guan, Qijun Wan. Triglyceride: A mediator of the association between waist-to-height ratio and non-alcoholic fatty liver disease: A second analysis of a population-based study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.973823
|
| 51 |
Keyang Zheng, Yuzhe Yin, Hang Guo, Linlin Ma, Rufei Liu, Tianzhu Zhao, Yuxuan Wei, Zixu Zhao, Wenli Cheng. Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1340644
|